Insurance price of Sprycel to be determined in mid-April

Published: 2008-03-25 06:59:00

Updated: 2008-03-25 06:59:00

The insurance coordination meeting aimed at determining the prices of Sprycel (dasatinib), BMS's leukemia medicine, will convene in the middle of next month, according to the Ministry of Health, Welfare and Family Affairs.

A ministry official said the meeting will be delayed until next month b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK